We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jul 2019 to Jul 2024
TIDMGWP
RNS Number : 1651J
GW Pharmaceuticals PLC
09 June 2014
GW Pharmaceuticals PLC ("GW Pharmaceuticals")
BLOCK LISTING APPLICATION
Porton Down, UK, 9 June 2014: GW Pharmaceuticals (AIM: GWP) hereby provides notification that application has today been made to the London Stock Exchange for admission to trading on AIM of four blocks of new ordinary shares of 0.1p each.
These new ordinary shares will be issued from time to time pursuant to the exercise of employee share options under the GW Pharmaceuticals share options schemes, as follows:
168,650 new ordinary shares for issue by the GW Pharmaceuticals Executive Management Incentive Share Option Scheme 2001.
122,613 new ordinary shares for issue by the GW Pharmaceuticals Company Share Option Scheme 2001
500,000 new ordinary shares for issue by the GW Pharmaceuticals Unapproved Share Option Scheme 2001.
500,000 new ordinary shares for issue by the GW Pharmaceuticals Long Term Incentive Plan 2008
On exercise the shares will be issued credited as fully paid and will rank pari passu with the existing ordinary shares in issue.
It is expected that such admission will become effective on 13 June 2014.
For further information, please contact:
GW Pharmaceuticals PLC +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser)
James Steel/Oliver Jackson +44 (0) 20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISSSDFFUFLSEDM
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
